EA200200307A1 - RADIOACTIVE PHARMACEUTICAL PRODUCTS AND METHOD FOR THEIR PRODUCTION - Google Patents

RADIOACTIVE PHARMACEUTICAL PRODUCTS AND METHOD FOR THEIR PRODUCTION

Info

Publication number
EA200200307A1
EA200200307A1 EA200200307A EA200200307A EA200200307A1 EA 200200307 A1 EA200200307 A1 EA 200200307A1 EA 200200307 A EA200200307 A EA 200200307A EA 200200307 A EA200200307 A EA 200200307A EA 200200307 A1 EA200200307 A1 EA 200200307A1
Authority
EA
Eurasian Patent Office
Prior art keywords
production
pharmaceutical products
products
radioactive pharmaceutical
radioactive
Prior art date
Application number
EA200200307A
Other languages
Russian (ru)
Inventor
Эмманюэль Белланд
Пьер Жалле
Бенуа Денизо
Original Assignee
Шеринг Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг Акциенгезелльшафт filed Critical Шеринг Акциенгезелльшафт
Publication of EA200200307A1 publication Critical patent/EA200200307A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Настоящее изобретение относится к радиоактивным фармацевтическим продуктам и способу их получения. Указанные продукты можно применять для сцинтиграфии легких или для лечения. Такие продукты содержат полисахарид с хелатообразующими группами формул R-NH-, R-N= игде R представляет собой углеводородную или ароматическую группу, содержащую, по меньшей мере, один атом серы, и R' представляет собой атом водорода или алкильную группу, такую как метил, причем указанные хелатообразующие группы образуют комплекс хелатного типа с радиоактивным металлом, таким как технеций.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to radioactive pharmaceutical products and method for their production. These products can be used for lung scintigraphy or for treatment. Such products contain a polysaccharide with chelating groups of the formulas R — NH—, RN = where R represents a hydrocarbon or aromatic group containing at least one sulfur atom, and R 'represents a hydrogen atom or an alkyl group such as methyl These chelating groups form a chelated complex with a radioactive metal, such as technetium. The international application was published along with an international search report.

EA200200307A 1999-09-01 2000-08-23 RADIOACTIVE PHARMACEUTICAL PRODUCTS AND METHOD FOR THEIR PRODUCTION EA200200307A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910970A FR2797769B1 (en) 1999-09-01 1999-09-01 RADIOPHARMACEUTICAL PRODUCTS AND THEIR PREPARATION PROCESS
PCT/IB2000/001161 WO2001015746A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Publications (1)

Publication Number Publication Date
EA200200307A1 true EA200200307A1 (en) 2002-08-29

Family

ID=9549465

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200307A EA200200307A1 (en) 1999-09-01 2000-08-23 RADIOACTIVE PHARMACEUTICAL PRODUCTS AND METHOD FOR THEIR PRODUCTION

Country Status (23)

Country Link
EP (1) EP1210127A1 (en)
JP (1) JP2003508455A (en)
KR (1) KR20020040799A (en)
CN (1) CN1371292A (en)
AU (1) AU6463100A (en)
BG (1) BG106438A (en)
BR (1) BR0013729A (en)
CA (1) CA2383517A1 (en)
CZ (1) CZ2002782A3 (en)
EA (1) EA200200307A1 (en)
EE (1) EE200200105A (en)
FR (1) FR2797769B1 (en)
HK (1) HK1044893A1 (en)
HU (1) HUP0202714A2 (en)
IL (1) IL148076A0 (en)
MX (1) MXPA02001923A (en)
NO (1) NO20021001L (en)
NZ (1) NZ517377A (en)
PL (1) PL353803A1 (en)
SK (1) SK2772002A3 (en)
WO (1) WO2001015746A1 (en)
YU (1) YU14202A (en)
ZA (1) ZA200201057B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
FR2919189A1 (en) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab NOVEL COMPOSITIONS BASED ON POLYOSIDES GRAFTED BY POLYAMINE OR POLYSOUFRE COMPOUNDS.
CN102977174B (en) * 2012-12-19 2015-04-22 北京师范大学 99mTc(CO)3 nuclear-labeled macrocyclic polyamine triazole ring glucose-based complex as well as preparation and application of complex
PL240772B1 (en) 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Method of producing polymer nanoparticles chelating radioactive isotopes for use in diagnostics and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7412164L (en) * 1974-09-27 1976-03-29 Pharmacia Ab FUNDS FOR INTRAVASCULAR ADMINISTRATION
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
DE69332952T2 (en) * 1992-09-04 2004-02-19 The General Hospital Corp., Boston Biocompatible polymers containing diagnostic and therapeutic units
US5958372A (en) * 1994-06-28 1999-09-28 Nycomed Imaging As Low viscosity chelating polymers for diagnostic imaging
FR2736834B1 (en) * 1995-07-17 1997-08-29 Cis Bio Int RADIOPHARMACEUTICAL PRODUCTS WITH CARDIAC TROPISM COMPRISING A NITRURO COMPLEX OF A TRANSITIONAL METAL AND HAVING FAST MYOCARDIAL CLEARANCE

Also Published As

Publication number Publication date
FR2797769A1 (en) 2001-03-02
HUP0202714A2 (en) 2002-12-28
BR0013729A (en) 2002-05-07
EP1210127A1 (en) 2002-06-05
WO2001015746A1 (en) 2001-03-08
JP2003508455A (en) 2003-03-04
ZA200201057B (en) 2003-07-30
MXPA02001923A (en) 2003-07-21
EE200200105A (en) 2003-04-15
NZ517377A (en) 2003-08-29
FR2797769B1 (en) 2003-07-25
YU14202A (en) 2004-09-03
BG106438A (en) 2002-09-30
CN1371292A (en) 2002-09-25
IL148076A0 (en) 2002-09-12
NO20021001L (en) 2002-04-11
KR20020040799A (en) 2002-05-30
HK1044893A1 (en) 2002-11-08
SK2772002A3 (en) 2002-09-10
AU6463100A (en) 2001-03-26
CA2383517A1 (en) 2001-03-08
NO20021001D0 (en) 2002-02-28
PL353803A1 (en) 2003-12-01
CZ2002782A3 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
EA200200307A1 (en) RADIOACTIVE PHARMACEUTICAL PRODUCTS AND METHOD FOR THEIR PRODUCTION
ES2059408T3 (en) A PROCESS FOR THE PREPARATION OF A COMPOUND.
MX9800867A (en) Halobenzimidazoles and their use as microbicides.
KR830009777A (en) Methods for preparing substances useful for the treatment of melanoma
HUP0302962A2 (en) Beta-carboline compounds, pharmaceutical compositions containing the compounds and their use
PT804427E (en) LTA4 HYDROLASE INHIBITORS
BR0111377A (en) Thiophene derivatives useful as anticancer agents
HUP9802814A2 (en) Selective beta3 adrenergic agonists, pharmaceutical compositions containing them, process for producing them and their use
HUP9901590A2 (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives, use thereof, pharmaceutical compositions containing these compounds
NL980012I2 (en) Mometasone furoate monohydrate, preparation method and pharmaceutical compositions.
DE3853415D1 (en) Macrocyclic chelating agents and chelates made therefrom.
CA2133270A1 (en) Quaternary Ammonium Hydroxides as Mercaptan Scavengers
EA200100516A1 (en) DERIVATIVES 3,3-BIARILPIPERIDINA AND 2,2-BIARYLMORPHOLINE
FR2673180B1 (en) NOVEL POLY-IODIC NON-IONIC COMPOUNDS, PREPARATION METHOD, CONTRAST PRODUCT CONTAINING THE SAME.
ATE211474T1 (en) GALANTHAMIN DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICATIONS
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
FR2713085B1 (en) Dye composition containing sulfur p-phenylenediamines and corresponding dyeing processes, new sulfur p-phenylenediamines and process for their preparation.
MXPA01013148A (en) Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use.
ES8308835A1 (en) Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application.
DK157489C (en) N-SUBSTITUTED PYRIDINIUM COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
ES8105704A1 (en) Oxime ethers and pharmaceutical compositions containing the same
FR2616663B1 (en) NOVEL NITROGEN POLYCYCLIC STRUCTURE TRIPEPTIDES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
DE69725133D1 (en) DIHYDROBENZOFURANES AND RELATED COMPOUNDS USEFUL AS AN ANTI-FLAMMING AGENT
DK558786A (en) BASIC SUBSTITUTED PYRIDINE COMPOUNDS, PREPARATION THEREOF, AND MEDICINES, CONTAINING THESE
HUP9700392A1 (en) Cardioprotective pharmaceutical compositions containing one or two active ingredients